vs
GoodRx Holdings, Inc.（GDRX）与LEGALZOOM.COM, INC.（LZ）财务数据对比。点击上方公司名可切换其他公司
GoodRx Holdings, Inc.的季度营收约是LEGALZOOM.COM, INC.的1.0倍（$194.8M vs $190.3M），LEGALZOOM.COM, INC.净利率更高（3.2% vs 2.8%，领先0.4%），LEGALZOOM.COM, INC.同比增速更快（17.7% vs -1.9%），GoodRx Holdings, Inc.自由现金流更多（$31.6M vs $28.0M），过去两年LEGALZOOM.COM, INC.的营收复合增速更高（4.5% vs -0.8%）
GoodRx是一家美国医疗健康企业，运营着远程医疗平台以及可免费使用的网站与移动应用，服务覆盖美国超75000家药店，可为用户追踪处方药价格、提供药品优惠折扣券，还支持用户在线问诊，获取部分品类药物的处方。
LegalZoom是2001年成立的美国在线法律科技与服务企业，依托独立律师网络、旗下自营律所，结合自助服务技术与专属顾问，为用户提供线上法律服务。核心业务涵盖遗嘱、生前信托设立，营业执照、许可证办理等商事合规服务，以及版权登记、商标申请，同时还提供律师推荐等相关配套服务。
GDRX vs LZ — 直观对比
营收规模更大
GDRX
是对方的1.0倍
$190.3M
营收增速更快
LZ
高出19.6%
-1.9%
净利率更高
LZ
高出0.4%
2.8%
自由现金流更多
GDRX
多$3.7M
$28.0M
两年增速更快
LZ
近两年复合增速
-0.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $194.8M | $190.3M |
| 净利润 | $5.4M | $6.1M |
| 毛利率 | — | 67.6% |
| 营业利润率 | 11.6% | 6.6% |
| 净利率 | 2.8% | 3.2% |
| 营收同比 | -1.9% | 17.7% |
| 净利润同比 | -19.5% | -52.9% |
| 每股收益（稀释后） | $0.02 | $0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GDRXLZ
| Q4 25 | $194.8M | $190.3M | ||
| Q3 25 | $196.0M | $190.2M | ||
| Q2 25 | $203.1M | $192.5M | ||
| Q1 25 | $203.0M | $183.1M | ||
| Q4 24 | $198.6M | $161.7M | ||
| Q3 24 | $195.3M | $168.6M | ||
| Q2 24 | $200.6M | $177.4M | ||
| Q1 24 | $197.9M | $174.2M |
净利润GDRXLZ
| Q4 25 | $5.4M | $6.1M | ||
| Q3 25 | $1.1M | $4.5M | ||
| Q2 25 | $12.8M | $-266.0K | ||
| Q1 25 | $11.1M | $5.1M | ||
| Q4 24 | $6.7M | $12.9M | ||
| Q3 24 | $4.0M | $11.1M | ||
| Q2 24 | $6.7M | $1.3M | ||
| Q1 24 | $-1.0M | $4.7M |
毛利率GDRXLZ
| Q4 25 | — | 67.6% | ||
| Q3 25 | — | 67.3% | ||
| Q2 25 | — | 65.0% | ||
| Q1 25 | — | 63.7% | ||
| Q4 24 | — | 67.0% | ||
| Q3 24 | — | 67.5% | ||
| Q2 24 | — | 64.1% | ||
| Q1 24 | — | 60.7% |
营业利润率GDRXLZ
| Q4 25 | 11.6% | 6.6% | ||
| Q3 25 | 7.5% | 3.4% | ||
| Q2 25 | 13.2% | -1.6% | ||
| Q1 25 | 11.5% | 4.9% | ||
| Q4 24 | 9.2% | 8.1% | ||
| Q3 24 | 10.5% | 9.6% | ||
| Q2 24 | 9.9% | 0.6% | ||
| Q1 24 | 3.7% | 2.9% |
净利率GDRXLZ
| Q4 25 | 2.8% | 3.2% | ||
| Q3 25 | 0.6% | 2.4% | ||
| Q2 25 | 6.3% | -0.1% | ||
| Q1 25 | 5.4% | 2.8% | ||
| Q4 24 | 3.4% | 7.9% | ||
| Q3 24 | 2.0% | 6.6% | ||
| Q2 24 | 3.3% | 0.7% | ||
| Q1 24 | -0.5% | 2.7% |
每股收益（稀释后）GDRXLZ
| Q4 25 | $0.02 | $0.03 | ||
| Q3 25 | $0.00 | $0.02 | ||
| Q2 25 | $0.04 | $0.00 | ||
| Q1 25 | $0.03 | $0.03 | ||
| Q4 24 | $0.01 | $0.07 | ||
| Q3 24 | $0.01 | $0.06 | ||
| Q2 24 | $0.02 | $0.01 | ||
| Q1 24 | $0.00 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $261.8M | $203.1M |
| 总债务越低越好 | $495.0M | — |
| 股东权益账面价值 | $616.3M | $171.9M |
| 总资产 | $1.4B | $511.5M |
| 负债/权益比越低杠杆越低 | 0.80× | — |
8季度趋势，按日历期对齐
现金及短期投资GDRXLZ
| Q4 25 | $261.8M | $203.1M | ||
| Q3 25 | $273.5M | $237.2M | ||
| Q2 25 | $281.3M | $217.0M | ||
| Q1 25 | $301.0M | $210.0M | ||
| Q4 24 | $448.3M | $142.1M | ||
| Q3 24 | $423.8M | $112.5M | ||
| Q2 24 | $524.9M | $118.8M | ||
| Q1 24 | $533.3M | $228.1M |
总债务GDRXLZ
| Q4 25 | $495.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $500.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益GDRXLZ
| Q4 25 | $616.3M | $171.9M | ||
| Q3 25 | $600.7M | $201.9M | ||
| Q2 25 | $643.0M | $194.1M | ||
| Q1 25 | $654.3M | $187.2M | ||
| Q4 24 | $724.7M | $93.3M | ||
| Q3 24 | $696.4M | $60.1M | ||
| Q2 24 | $669.4M | $60.8M | ||
| Q1 24 | $631.1M | $167.9M |
总资产GDRXLZ
| Q4 25 | $1.4B | $511.5M | ||
| Q3 25 | $1.3B | $551.1M | ||
| Q2 25 | $1.3B | $543.0M | ||
| Q1 25 | $1.3B | $532.7M | ||
| Q4 24 | $1.4B | $373.9M | ||
| Q3 24 | $1.4B | $348.8M | ||
| Q2 24 | $1.5B | $359.5M | ||
| Q1 24 | $1.5B | $459.7M |
负债/权益比GDRXLZ
| Q4 25 | 0.80× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.69× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $32.9M | $34.1M |
| 自由现金流经营现金流 - 资本支出 | $31.6M | $28.0M |
| 自由现金流率自由现金流/营收 | 16.2% | 14.7% |
| 资本支出强度资本支出/营收 | 0.6% | 3.2% |
| 现金转化率经营现金流/净利润 | 6.06× | 5.63× |
| 过去12个月自由现金流最近4个季度 | $164.4M | $147.9M |
8季度趋势，按日历期对齐
经营现金流GDRXLZ
| Q4 25 | $32.9M | $34.1M | ||
| Q3 25 | $76.0M | $54.2M | ||
| Q2 25 | $49.6M | $39.1M | ||
| Q1 25 | $9.4M | $50.7M | ||
| Q4 24 | $44.7M | $42.6M | ||
| Q3 24 | $86.9M | $31.6M | ||
| Q2 24 | $9.7M | $27.2M | ||
| Q1 24 | $42.6M | $34.2M |
自由现金流GDRXLZ
| Q4 25 | $31.6M | $28.0M | ||
| Q3 25 | $74.3M | $47.0M | ||
| Q2 25 | $49.2M | $31.6M | ||
| Q1 25 | $9.3M | $41.3M | ||
| Q4 24 | $44.6M | $35.9M | ||
| Q3 24 | $86.5M | $22.0M | ||
| Q2 24 | $9.4M | $17.4M | ||
| Q1 24 | $42.2M | $24.7M |
自由现金流率GDRXLZ
| Q4 25 | 16.2% | 14.7% | ||
| Q3 25 | 37.9% | 24.7% | ||
| Q2 25 | 24.2% | 16.4% | ||
| Q1 25 | 4.6% | 22.6% | ||
| Q4 24 | 22.4% | 22.2% | ||
| Q3 24 | 44.3% | 13.0% | ||
| Q2 24 | 4.7% | 9.8% | ||
| Q1 24 | 21.3% | 14.2% |
资本支出强度GDRXLZ
| Q4 25 | 0.6% | 3.2% | ||
| Q3 25 | 0.9% | 3.8% | ||
| Q2 25 | 0.2% | 3.9% | ||
| Q1 25 | 0.1% | 5.1% | ||
| Q4 24 | 0.1% | 4.1% | ||
| Q3 24 | 0.2% | 5.7% | ||
| Q2 24 | 0.1% | 5.6% | ||
| Q1 24 | 0.2% | 5.4% |
现金转化率GDRXLZ
| Q4 25 | 6.06× | 5.63× | ||
| Q3 25 | 67.94× | 12.03× | ||
| Q2 25 | 3.86× | — | ||
| Q1 25 | 0.85× | 9.89× | ||
| Q4 24 | 6.64× | 3.31× | ||
| Q3 24 | 21.91× | 2.86× | ||
| Q2 24 | 1.45× | 20.74× | ||
| Q1 24 | — | 7.21× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GDRX
| Prescription Transactions Revenue | $124.7M | 64% |
| Other | $44.4M | 23% |
| Subscription Revenue | $21.6M | 11% |
| Other Revenue | $4.1M | 2% |
LZ
暂无分部数据
